Rochester Beacon (https://rochesterbeacon.com/category/health-science/)
It’s now been a half-decade since the start of the COVID-19 pandemic, which has claimed more than 3,350 lives in the Rochester area and 7 million worldwide. For many people who lived through the pandemic, the experience has had a profound and lasting impact.
The funds from the Pluta Cancer Foundation will boost recruitment and retention initiatives, and help fund clinical trials.
The bulk of the commitment to the University of Rochester Medical Center by entrepreneur and philanthropist Philip Saunders will support the work of the UR Medicine Orthopaedics & Physical Performance Center.
The medical system has taken action in response to a nationwide shortage of intravenous sterile fluids. The pause begins Oct. 16.
For decades, Rochester-area health institutions have struggled to find enough beds for patients who need skilled nursing care. Since COVID, the problem has grown much worse.
A $1 million donation from alumnae and business leaders Peter and Kathleen Landers will support the hospital’s ongoing expansion project.
The University of Rochester Medical Center, whose UR Medicine system is the region’s largest health care provider, is trying to rein in skyrocketing labor costs.
The funds, for the first large-scale, head-to-head comparison of two heart failure drugs, brings to $54 million the total received by the URMC cardiac research team in four months.
CannaMetrix aims to provide medically relevant, biological endpoint metrics for validating the quality and potency of cannabis products.
Since the state’s takeover of the Medicaid prescription drug program last year, safety net hospitals and clinics—those serving Medicaid, uninsured and underinsured patients—have been reeling from the loss of drug company discounts.
The gift will establish the Golisano Intellectual and Developmental Disabilities Institute at the UR Medical Center.
